---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-044940"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2025-12-09T23:59:59+00:00"
generated_at: "2026-05-16T13:47:13.580713+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech receives broad Japanese patent for lead candidate PDS0101

## Summary
- Japan Patent Office issued Patent No. 7783866 for PDS0101 covering broad composition of matter and methods of use.
- Patent expands PDS Biotech's IP portfolio in Japan; previously granted patents in US, China, Australia, Hong Kong.
- Company anticipates patent and market protections for PDS0101 into the 2040s, including US biologics exclusivity.
- PDS0101 is in Phase 3 trial for HPV16-positive recurrent/metastatic head and neck cancer.
- CEO Frank Bedu-Addo stated the patent strengthens global IP and supports growth.

## SEC filing metadata
- accession: 0001140361-25-044940
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2025-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/0001140361-25-044940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/ef20060919_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-044940
- JSON: https://secwatch.observer/filing/0001140361-25-044940.json
- Plain text: https://secwatch.observer/filing/0001140361-25-044940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.